These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3087014)

  • 1. Inhibition of tissue thromboplastin-mediated blood coagulation.
    Hubbard AR; Jennings CA
    Thromb Res; 1986 May; 42(4):489-98. PubMed ID: 3087014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions.
    Sandset PM; Abildgaard U; Pettersen M
    Thromb Res; 1987 Aug; 47(4):389-400. PubMed ID: 3499007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between human tissue thromboplastin and human antithrombin III.
    Hirahara K; Matsuishi T; Suzuki N; Kurata M
    Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):2984-7. PubMed ID: 2632043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.
    Welsch DJ; Novotny WF; Wun TC
    Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the tissue factor-factor VII complex: involvement of factor Xa and lipoproteins.
    Hubbard AR; Jennings CA
    Thromb Res; 1987 May; 46(4):527-37. PubMed ID: 3617011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin.
    Sandset PM; Abildgaard U
    Haemostasis; 1991; 21(4):219-39. PubMed ID: 1794748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of antithrombin III, activated protein C and heparin on the inhibition of the tissue thromboplastin-mediated coagulation.
    Hirahara K; Etoh Y; Matsuishi T; Suzuki N; Kurata M
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):692-6. PubMed ID: 2752479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anticoagulant effect in heparinized blood and plasma resulting from interactions with extrinsic pathway inhibitor.
    Lindahl AK; Abildgaard U; Staalesen R
    Thromb Res; 1991 Oct; 64(2):155-68. PubMed ID: 1811336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel anticoagulant activity of polyamino acid offsets bacterial endotoxin-induced extrinsic hypercoagulation: downregulation of monocytic tissue factor-dependent FVII activation.
    Chu AJ; Rauci M; Nwobi OI; Mathews ST; Beydoun S
    J Cardiovasc Pharmacol; 2003 Oct; 42(4):477-83. PubMed ID: 14508232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A peptide sequence from the EGF-2 like domain of FVII inhibits TF-dependent FX activation.
    Orning L; Stephens RW; Petersen LB; Hamers MJ; Stormorken H; Sakariassen KS
    Thromb Res; 1997 Apr; 86(1):57-67. PubMed ID: 9172287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. III. Instantaneous inhibition by compound 48/80 of tissue factor-initiated extrinsic coagulation is mediated by the downregulation of factor VII activation.
    Chu AJ; Wang ZG; Fox MJ
    Arch Biochem Biophys; 2000 May; 377(2):357-65. PubMed ID: 10845714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compound 48/80 suppresses monocytic tissue factor-initiated extrinsic blood coagulation induced by bacterial endotoxin.
    Chu AJ; Raphael UO; Prasad JK; Beydoun S; Ramos N
    J Surg Res; 1999 Dec; 87(2):252-7. PubMed ID: 10600357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrinsic pathway inhibitor (EPI) and the post-heparin anticoagulant effect in tissue thromboplastin induced coagulation.
    Lindahl AK; Abildgaard U; Larsen ML; Aamodt LM; Nordfang O; Beck TC
    Thromb Res Suppl; 1991; 14():39-48. PubMed ID: 1658969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a calcium binding site in the protease domain of human blood coagulation factor VII: evidence for its role in factor VII-tissue factor interaction.
    Wildgoose P; Foster D; Schiødt J; Wiberg FC; Birktoft JJ; Petersen LC
    Biochemistry; 1993 Jan; 32(1):114-9. PubMed ID: 8418832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitors of the tissue factor:factor VII pathway.
    Golino P
    Thromb Res; 2002 May; 106(3):V257-65. PubMed ID: 12356487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII.
    Idell S; Gonzalez K; Bradford H; MacArthur CK; Fein AM; Maunder RJ; Garcia JG; Griffith DE; Weiland J; Martin TR
    Am Rev Respir Dis; 1987 Dec; 136(6):1466-74. PubMed ID: 3688650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protamine inhibits tissue factor-initiated extrinsic coagulation.
    Chu AJ; Wang ZG; Raicu M; Beydoun S; Ramos N
    Br J Haematol; 2001 Nov; 115(2):392-9. PubMed ID: 11703341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade by ruthenium red of tissue factor-initiated coagulation.
    Chu AJ; Wang ZG; Nwobi OI; Beydoun S
    Br J Pharmacol; 2001 Jul; 133(5):659-64. PubMed ID: 11429389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation.
    Rapaport SI
    Thromb Haemost; 1991 Jul; 66(1):6-15. PubMed ID: 1926052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.